Stock Market & Financial Investment News

News Breaks January 28, 2013 10:09 EDT FURX Furiex price target raised to $38 from $33 at Ladenburg Ladenburg raised its price target for Furiex after the FDA approved Nesina for the treatment of Type 2 Diabetes. The firm reiterates a Buy rating on the stock. News For FURX From The Last 14 Days Check below for free stories on FURX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for FURX Sign up for a free trial to see the rest of the stories you've been missing.